Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessHighly AccessCase report

Primary small-cell neuroendocrine carcinoma of the duodenum – a case report and review of literature

Naohiro Sata1 email, Munetoshi Tsukahara1 email, Masaru Koizumi1 email, Koji Yoshizawa1 email, Katsumi Kurihara1 email, Hideo Nagai1 email, Tsutomu Someya2 email and Ken Saito2 email

Department of Surgery, Jichi Medical School, 3311-1 Yakushiji Minami-kawachi Tochigi, Japan

Department of Pathology, Jichi Medical School, 3311-1 Yakushiji Minami-kawachi Tochigi, Japan

author email corresponding author email

World Journal of Surgical Oncology 2004, 2:28doi:10.1186/1477-7819-2-28

Published: 15 August 2004

Abstract

Background

Small-cell neuroendocrine carcinoma in the duodenum is an extremely rare neoplasm with poor prognosis.

Case presentation

A 57-year-old man presented with sudden onset gastrointestinal bleeding and fainting attacks. Duodenoscopy and hypotonic duodenography revealed a 3 × 3 cm protruding tumor with ulcerations situated opposite the ampulla of Vater in the second part of the duodenum. Local excision of the tumor was performed, followed by adjuvant chemotherapy with 5-fluoro uracil and leucovorin. Examination of the tumor by immunohistochemistry and electron microscopy indicated it to be neuroendocrine in nature, expressing synaptophysin and AE1/AE3, and containing dense core granules. The patient showed no sign of recurrence and has been disease-free for more than 48 months after surgery.

Conclusions

Most cases of small-cell neuroendocrine carcinoma in the duodenum show rapid progression of the disease, and even radical surgery with or without chemotherapy do not prevent death. We report a rare subtype of small-cell neuroendocrine carcinoma. This subtype appears to have a much better prognosis, and may be amenable to local excision, if the lesion is away from the ampulla of Vater.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.